Seed · Biotech · Hamburg, Germany · Founded 2023 · 1–10 employees
mo:re is a Hamburg-based TechBio startup revolutionizing drug development through its laboratory platform that automates advanced 3D cell culture workflows, particularly organoids, to replace animal testing. The company integrates hardware and software to standardize and digitize complex cell culture experiments, enabling animal-free research with reproducible results. mo:re recently raised €2.3 million in seed funding led by High-Tech Gründerfonds to accelerate commercialization of their platform. The startup launched their first product at SLAS 2025 in San Diego and has developed a protocol database that provides validated organoid know-how for pharmaceutical and biotechnology institutions.